AI LABS BOOST BIOLOGICAL RISK TESTING

Frontier AI labs face a unique challenge: while cybersecurity vulnerabilities can be tested in controlled digital environments, biological risks require different assessment approaches. Executives and biosecurity experts worry that advanced AI models could potentially assist users in creating novel viruses or bioweapons. This concern has prompted increased testing protocols at major labs. Unlike cyberattacks that can be simulated and contained digitally, biological risk assessment demands more complex evaluation methods. Labs must consider how AI systems might be misused to accelerate dangerous biological research or synthesis. The shift reflects growing recognition that AI safety requires more than traditional security measures. As models become more capable, the potential dual-use applications expand, making comprehensive biosecurity testing essential before deployment. This testing uptick comes amid broader industry efforts to identify and mitigate risks from increasingly powerful AI systems.